LAZAR DAVID E. purchased 1.7% of their position (57.50K shares) of TITAN PHARMACEUTICALS INC on the open market
Open‑market purchase worth $56.3K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 1/26/2023ACC: 0000921895-23-000200
+57.50K
Net shares
Net buyer
$56.3K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
57.50K acquired
Non-Derivative Transactions2
Common Stock, par value $0.001
Direct
Shares
+37.50K
Price / share
$0.97
Trade value
$36.22K
% of position
1.1%
1/24/2023
3.33M→3.37M
Common Stock, par value $0.001
Direct
Shares
+20K
Price / share
$1.00
Trade value
$20.07K
% of position
0.6%
1/25/2023
3.37M→3.39M
Total
Net shares
+57.50K
Net value
$56.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 Direct | 1/24/2023 | P · Purchase | +37.50K | $0.97 | $36.22K | 1.1% | 3.33M | 3.37M |
| Common Stock, par value $0.001 Direct | 1/25/2023 | P · Purchase | +20K | $1.00 | $20.07K | 0.6% | 3.37M | 3.39M |
| Total | +57.50K | $56.29K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, par value $0.001
IndirectShares owned359.07K
Total
359.07K indirect359.07K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.001 | 359.07K | Indirect |
| Total | 359.07K | 359.07K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported